• Antiaging Quantum Living posted a net loss of USD 837,646, widening 16.27% in fiscal 2026.
• Revenue rose 26.47% to USD 1.03 million, while operating loss widened 5.75% to USD 835,401.
• Gross margin climbed 15.5 percentage points to 67.9%, as selling, general and administrative expenses increased 26.18% to USD 1.54 million.
• FY 2026 revenue included USD 141,828 from therapy services and USD 180,950 from proprietary health/beauty products as the company exited online platform technical services.
• Cash and cash equivalents totaled about USD 503,486 at March 31, 2026, with a working capital deficit of USD 459,038.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Antiaging Quantum Living Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033212), on July 14, 2026, and is solely responsible for the information contained therein.